Insulin-like growth factor binding proteins in metabolic dysfunction-associated steatotic liver disease - Top-Institutions - MDSpire

Insulin-like growth factor binding proteins in metabolic dysfunction-associated steatotic liver disease

  • By

  • Kuo Fang

  • Ji Miao

  • Guobin Song

  • June 5, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Endocrinology
    • Metabolism
    • Liver Disease

  • #2

    University of Helsinki & Helsinki University Hospital
    University of Helsinki & Helsinki University Hospital

    Helsinki, Finland

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Liver Disease

Original Source(s)

Insulin-like growth factor binding proteins in metabolic dysfunction-associated steatotic liver disease

  • by Kuo Fang, Ji Miao, Guobin Song

  • June 5, 2026

Related Content

Laparoscopic Roux-en-Y Gastric Bypass with the Maestro™ System: a Novel Collaborative Robotic Platform

Probiotic Effect on Quality of Life, Bowel Habits and Weight Loss after Different Types of Bariatric Surgeries, a Randomized Controlled Trial

Case Report: rapid progressive puberty in siblings with MC4R p. Arg165Gln: longitudinal follow-up and gonadotropin-releasing hormone agonist treatment